eMedicine Specialties > Dermatology > Diseases of the Vessels

Benign Lymphangioendothelioma: Follow-up

Author: Walter HC Burgdorf, MD, Clinical Lecturer, Department of Dermatology, Ludwig Maximilian University, Munich, Germany
Contributor Information and Disclosures

Updated: Mar 10, 2009

Follow-up

Further Outpatient Care

Annual follow-up care is recommended for benign lymphangioendothelioma (BLAE) patients because of the possibility of local recurrence or misdiagnosis of angiosarcoma or Kaposi sarcoma.

Complications

Complications are usually only those associated with surgery and laser treatment, such as scarring and pigmentary change.

Prognosis

The prognosis is excellent.

Patient Education

Inform patients they have a rare vascular tumor that is poorly understood; thus, they should receive follow-up care.

Miscellaneous

Medicolegal Pitfalls

The problem with benign lymphangioendothelioma is the possible overdiagnosis of a serious, possibly fatal vascular malignancy when the entire clinical picture and histologic features are not considered. One should diagnose Kaposi sarcoma and angiosarcoma only in the appropriate clinical setting, not on the basis of histologic findings alone. Most dermatopathologists and surgical pathologists have little experience with benign lymphangioendothelioma; therefore, an expert should always be consulted.

 


More on Benign Lymphangioendothelioma

Overview: Benign Lymphangioendothelioma
Differential Diagnoses & Workup: Benign Lymphangioendothelioma
Treatment & Medication: Benign Lymphangioendothelioma
Follow-up: Benign Lymphangioendothelioma
Multimedia: Benign Lymphangioendothelioma
References
[ CLOSE WINDOW ]

References

  1. Guillou L, Fletcher CD. Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series. Am J Surg Pathol. Aug 2000;24(8):1047-57. [Medline].

  2. Requena L, Sangueza OP. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms. J Am Acad Dermatol. Dec 1997;37(6):887-919; quiz 920-2. [Medline].

  3. Jones EW, Winkelmann RK, Zachary CB, Reda AM. Benign lymphangioendothelioma. J Am Acad Dermatol. Aug 1990;23(2 Pt 1):229-35. [Medline].

  4. Hwang LY, Guill CK, Page RN, Hsu S. Acquired progressive lymphangioma. J Am Acad Dermatol. Nov 2003;49(5 Suppl):S250-1. [Medline].

  5. Kim HS, Kim JW, Yu DS. Acquired progressive lymphangioma. J Eur Acad Dermatol Venereol. Mar 2007;21(3):416-7. [Medline].

  6. Kato H, Kadoya A. Acquired progressive lymphangioma occurring following femoral arteriography. Clin Exp Dermatol. Mar 1996;21(2):159-62. [Medline].

  7. Paik AS, Lee PH, O'Grady TC. Acquired progressive lymphangioma in an HIV-positive patient. J Cutan Pathol. Nov 2007;34(11):882-5. [Medline].

  8. Herron GS, Rouse RV, Kosek JC, Smoller BR, Egbert BM. Benign lymphangioendothelioma. J Am Acad Dermatol. Aug 1994;31(2 Pt 2):362-8. [Medline].

  9. Watanabe M, Kishiyama K, Ohkawara A. Acquired progressive lymphangioma. J Am Acad Dermatol. May 1983;8(5):663-7. [Medline].

  10. Grunwald MH, Amichai B, Avinoach I. Acquired progressive lymphangioma. J Am Acad Dermatol. Oct 1997;37(4):656-7. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

benign lymphangioendothelioma, acquired progressive lymphangioma, BLAE,  Kaposi sarcoma, KS, angiosarcoma, targetoid hemosiderotic hemangioma

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Walter HC Burgdorf, MD, Clinical Lecturer, Department of Dermatology, Ludwig Maximilian University, Munich, Germany
Walter HC Burgdorf, MD is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, American Society of Dermatopathology, International Society of Dermatopathology, and Society for Pediatric Dermatology
Disclosure: Nothing to disclose.

Medical Editor

Gregory J Raugi, MD, PhD, Professor, Department of Internal Medicine, Division of Dermatology, University of Washington at Seattle; Chief, Dermatology Section, Primary and Specialty Care Service, Veterans Administration Medical Center of Seattle
Gregory J Raugi, MD, PhD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Managing Editor

Rosalie Elenitsas, MD, Herman Beerman Associate Professor of Dermatology, University of Pennsylvania School of Medicine; Director, Penn Cutaneous Pathology Services, Department of Dermatology, University of Pennsylvania Health System
Rosalie Elenitsas, MD is a member of the following medical societies: American Academy of Dermatology and American Society of Dermatopathology
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.